ID

19910

Descripción

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form is to be obtained in Screening.

Palabras clave

Versiones (1)
  1. 30/1/17 30/1/17 -
Subido en

30 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

MS Diagnostic Criteria CRFs Multiple Sclerosis Tysabri NCT00027300

Inglés

MS Diagnostic Criteria CRFs Multiple Sclerosis Tysabri NCT00027300

1 formularios  
MS Diagnostic Criteria
Descripción

MS Diagnostic Criteria

Alias
UMLS CUI-1
C0026769
UMLS CUI-2
C0679228
2 or more clinical attacks; 2 or more objective Lesions; none additional Requirements to Make Diagnosis: clinical evidence will suffice (additional evidence desirable but must be consistent with MS.)
Descripción

1. 2 or more clinical attacks, 2 or more objective Lesions and none additional Requirements

Tipo de datos

integer

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0221198
UMLS CUI [3,1]
C3887511
UMLS CUI [3,2]
C0205210
2 or more clinical attacks; 1 objective Lesion; Additional Requirements to Make Diagnosis: Dissemination is SPACE by MRI OR positive CSF and 2 more MRI lesions constant wit MS OR further clinical attack involving different site
Descripción

2.. 2 or more clinical attacks, 1 objective Lesion and Dissemination in space

Tipo de datos

integer

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0221198
UMLS CUI [3,1]
C3887511
UMLS CUI [3,2]
C0205210
1 clinical attack; 2 or more objective Lesions; Additional Requirements to Make Diagnosis: Dissemination in TIME by MRI OR second clinical attack
Descripción

3. 1 clinical attack, 2 or more objective Lesions and Dissemination in time

Tipo de datos

integer

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0221198
UMLS CUI [3,1]
C3887511
UMLS CUI [3,2]
C0205210
1 (monosymptomatic) clinical attack; 1 objective Lesion; Additional Requirements to Make Diagnosis: Dissemination in SPACE by MRI OR positive CSF and 2 or more MRI lesions consitent with MS AND Dissemination in TIME by MRI OR second clinical attack
Descripción

4. 1 clinical attack, 1 objective Lesion and Dissemination in space AND time

Tipo de datos

integer

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0221198
UMLS CUI [3,1]
C3887511
UMLS CUI [3,2]
C0205210
Volver a la parte superior de la página

Similar models

MS Diagnostic Criteria CRFs Multiple Sclerosis Tysabri NCT00027300

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
MS Diagnostic Criteria
C0026769 (UMLS CUI-1)
C0679228 (UMLS CUI-2)
1. 2 or more clinical attacks, 2 or more objective Lesions and none additional Requirements
Item
2 or more clinical attacks; 2 or more objective Lesions; none additional Requirements to Make Diagnosis: clinical evidence will suffice (additional evidence desirable but must be consistent with MS.)
integer
C0026769 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C3887511 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
2.. 2 or more clinical attacks, 1 objective Lesion and Dissemination in space
Item
2 or more clinical attacks; 1 objective Lesion; Additional Requirements to Make Diagnosis: Dissemination is SPACE by MRI OR positive CSF and 2 more MRI lesions constant wit MS OR further clinical attack involving different site
integer
C0026769 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C3887511 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
3. 1 clinical attack, 2 or more objective Lesions and Dissemination in time
Item
1 clinical attack; 2 or more objective Lesions; Additional Requirements to Make Diagnosis: Dissemination in TIME by MRI OR second clinical attack
integer
C0026769 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C3887511 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
4. 1 clinical attack, 1 objective Lesion and Dissemination in space AND time
Item
1 (monosymptomatic) clinical attack; 1 objective Lesion; Additional Requirements to Make Diagnosis: Dissemination in SPACE by MRI OR positive CSF and 2 or more MRI lesions consitent with MS AND Dissemination in TIME by MRI OR second clinical attack
integer
C0026769 (UMLS CUI [1])
C0221198 (UMLS CUI [2])
C3887511 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial